Publication | Closed Access
Efficacy and safety of <scp>SQ</scp> house dust mite sublingual immunotherapy‐tablet in Japanese children
103
Citations
28
References
2018
Year
This trial, for the first time, demonstrated the efficacy and safety of the HDM SLIT-tablet in pediatric patients with moderate-to-severe HDM AR (JapicCTI-152953).
| Year | Citations | |
|---|---|---|
Page 1
Page 1